Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Current Treatment Options in Cardiovascular Medicine
|
March 3, 2018
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers
Kelly C Gast, Paul V Viscuse, Somaira Nowsheen, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2021
Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer
Daniel Westaby, Paul V Viscuse, Rahul Ravilla, et al.
Frontiers in Oncology
|
March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
Paul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Cancers
|
December 23, 2023
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments
Paul V Viscuse, Rebecca S Slack-Tidwell, Miao Zhang, et al.
The Oncologist
|
November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy
Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer
Jack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, et al.
Cancers
|
May 27, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis
Evan R Adler, Anwaruddin Mohammad, Pankaj Kumar, et al.
European Urology Focus
|
March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
Andrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Iscience
|
June 15, 2026
Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers
Elavarasan Subramani, Patrick G Pilié, Rebecca Slack-Tidwell, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Current Treatment Options in Cardiovascular Medicine
|
March 3, 2018
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers
Kelly C Gast, Paul V Viscuse, Somaira Nowsheen, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2021
Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer
Daniel Westaby, Paul V Viscuse, Rahul Ravilla, et al.
Frontiers in Oncology
|
March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
Paul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Cancers
|
December 23, 2023
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments
Paul V Viscuse, Rebecca S Slack-Tidwell, Miao Zhang, et al.
The Oncologist
|
November 30, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy
Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer
Jack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, et al.
Cancers
|
May 27, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis
Evan R Adler, Anwaruddin Mohammad, Pankaj Kumar, et al.
European Urology Focus
|
March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
Andrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Iscience
|
June 15, 2026
Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers
Elavarasan Subramani, Patrick G Pilié, Rebecca Slack-Tidwell, et al.
Page
of 2